Literature DB >> 8581544

A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977-1993.

N J Laste1, N K Harpster.   

Abstract

The medical records of 100 cats with distal aortic thromboembolism were reviewed. The average age was 7.7 years, with the neutered male being the most common signalment (63%). Evidence of preexisting cardiac disease was noted in 11% of the cases. A murmur or arrhythmia was noted in 57% of the cases on presentation. Frequent laboratory abnormalities included elevations in blood glucose, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, and creatinine. Radiographic and electrocardiographic abnormalities were common (89% and 85%, respectively). The most frequent, underlying disease was hypertrophic feline cardiomyopathy (58%), with the left atrial size (as measured by M-mode) significantly increased in the majority of cases (mean left atrial-to-aortic ratio, 2.08). The average, long-term survival in the 37% of cases which survived the initial thromboembolic episode was 11.5 months. The remaining cases either died (28%) or were euthanized (35%).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581544     DOI: 10.5326/15473317-31-6-492

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  22 in total

1.  Specific contrast ultrasound using sterically stabilized microbubbles for early diagnosis of thromboembolic disease in a rabbit model.

Authors:  Michal Vlašín; Robert Lukáč; Zuzana Kauerová; Pavel Kohout; Josef Mašek; Eliška Bartheldyová; Štěpán Koudelka; Zina Korvasová; Jana Plocková; Nikola Hronová; Jaroslav Turánek
Journal:  Can J Vet Res       Date:  2014-04       Impact factor: 1.310

2.  Monoparesis in association with feline pulmonary carcinoma: a literature review with 3 new cases.

Authors:  Lucinda van Stee; Sarah Boston; Ameet Singh; Fiona Park; Danielle Richardson; Anthony Abrams-Ogg; Andrew Vince
Journal:  Can Vet J       Date:  2014-09       Impact factor: 1.008

3.  Validation of a method for quantitation of the clopidogrel active metabolite, clopidogrel, clopidogrel carboxylic acid, and 2-oxo-clopidogrel in feline plasma.

Authors:  Janne G Lyngby; Michael H Court; Pamela M Lee
Journal:  J Vet Cardiol       Date:  2017-06-09       Impact factor: 1.701

4.  Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats.

Authors:  Avril Hamel-Jolette; Marilyn Dunn; Christian Bédard
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

5.  Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease.

Authors:  Sara T Lo; Ashley L Walker; Catherine J Georges; Ronald Hl Li; Joshua A Stern
Journal:  J Feline Med Surg       Date:  2021-05-10       Impact factor: 2.015

6.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

7.  Concurrent diseases and conditions in cats with renal infarcts.

Authors:  Steve Valeika
Journal:  J Vet Intern Med       Date:  2014 Sep-Oct       Impact factor: 3.333

8.  A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy.

Authors:  Yu Ueda; Ronald H L Li; Nghi Nguyen; Eric S Ontiveros; Samantha L Kovacs; Maureen S Oldach; Karen M Vernau; Michael H Court; Joshua A Stern
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

9.  Arterial thromboembolism in 250 cats in general practice: 2004-2012.

Authors:  K Borgeat; J Wright; O Garrod; J R Payne; V L Fuentes
Journal:  J Vet Intern Med       Date:  2013-11-15       Impact factor: 3.333

10.  Concurrent diseases and conditions in cats with renal infarcts.

Authors:  M C Hickey; K Jandrey; K S Farrell; D Carlson-Bremer
Journal:  J Vet Intern Med       Date:  2014-02-16       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.